Follistatin 344
FS-344, Activin-Binding Protein, FST344
Follistatin-344 is a 344-amino acid peptide that antagonizes myostatin and activin, promoting muscle growth, regeneration, and inhibiting muscle wasting.
Completed
NA
NCT04112875
Effect of L-arginine on Microcirculation, Myogenesis and Angiogenesis Associated With Aging, Sarcopenia and Diabetes
Rio de Janeiro State University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT03050944
Association of the Mediterranean Diet With Fertility Outcomes
Harokopio University
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE1, PHASE2
NCT01856868
Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)
Craig McDonald, MD
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT02895178
Lifestyles Of Health And Sustainability for Breast Cancer Survivors
Wonju Severance Christian Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Not Yet Recruiting
NA
NCT07005193
Effects of LPG and Ventilation Interventions on Reducing HAP and Improving Cardiopulmonary Health
Huazhong University of Science and Technology
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT06359444
Effect of High Intensity Exercise Rehabilitation on Liver Function and Insulin Sensitivity in Patients With MASLD
University Ghent
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT06229899
Follistatin Levels in Metabolically Healthy and Unhealthy Obese Individuals
Goztepe Prof Dr Suleyman Yalcın City Hospital
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT01519349
Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis
Nationwide Children's Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT05632484
Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia
Hospices Civils de Lyon
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT06411366
Phase I: Safety and Efficacy of an Injectable Follistatin Plasmid Gene Therapy in Humans
Minicircle
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT04907721
Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic Steatosis
University of Copenhagen
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT03986684
Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease
Hippocration General Hospital
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT04386304
Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy
Epirium Bio Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
EARLY PHASE1
NCT00734279
Follicle-Stimulating Hormone (FSH) and the Onset of Puberty
University of Utah
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NCT02739048
Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation.
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OBSERVATIONAL
Updated Dec 15, 2025
Recruiting
NCT07236970
Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic Sclerosis
Alejandro Cruz Utrilla
OBSERVATIONAL
Updated Dec 15, 2025
Recruiting
PHASE2
NCT05924100
Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD
Associazione Qol-one
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT05520749
Efficacy and Safety of Luspatercept: a Study by Fondazione Italiana Sindromi Mielodisplastiche
Fondazione Italiana Sindromi Mielodisplastiche-ETS
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT01237054
Imaging in MGUS, SMM and MM
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT04354233
A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast Cancer
Centre Leon Berard
INTERVENTIONAL
Updated Dec 15, 2025